What obesity drugmakers see next in the market: More pills, easier access and drug combinations ⊕
found
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
JPMorgan Healthcare Conference
since
auto-detected in 2 stories
4 months ago
CNBC spoke to executives from Eli Lilly, Novo Nordisk, Pfizer and other drugmakers at the annual JPMorgan Healthcare Conference in San Francisco.
Healthy Returns: Novo Nordisk CEO on GLP-1 pricing, and more insights from the JPM conference ⊕
found
Novo Nordisk's CEO spoke about GLP-1 pricing and Pfizer's CEO spoke about the company's obesity ambitions while at the JPMorgan Healthcare Conference.
page 1 of 1